US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
US2180006A
(en)
|
1936-09-09 |
1939-11-14 |
Eastman Kodak Co |
Process for the separation and refining of amines
|
GB891817A
(en)
*
|
1959-04-07 |
1962-03-21 |
Upjohn Co |
Improvements in or relating to injectable tetracyclic preparations
|
GB891617A
(en)
|
1959-09-02 |
1962-03-14 |
Clifford Brothers Ltd |
Lever handle for operating a latch or the spring bolt in a lock
|
US3843787A
(en)
*
|
1969-01-15 |
1974-10-22 |
Pierrel Spa |
Water soluble derivative of erythromycin
|
US3668282A
(en)
|
1970-05-08 |
1972-06-06 |
Stauffer Chemical Co |
Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
|
US3843767A
(en)
|
1972-03-27 |
1974-10-22 |
Du Pont |
Process for treating fluophosphate ores
|
SE458505B
(sv)
*
|
1979-07-10 |
1989-04-10 |
Lepetit Spa |
Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
JPS59104326A
(ja)
*
|
1982-12-04 |
1984-06-16 |
Toyo Jozo Co Ltd |
マクロライド抗生物質の安定な経口用製剤および安定化法
|
JPS59175414A
(ja)
*
|
1983-03-23 |
1984-10-04 |
Toyo Jozo Co Ltd |
マクロライド抗生物質の安定な経口用製剤および安定化法
|
US4742049A
(en)
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
KR960000434B1
(ko)
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
EP0283055B1
(en)
|
1987-09-03 |
1990-08-29 |
SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. |
10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
|
BE1001869A3
(fr)
*
|
1988-10-12 |
1990-04-03 |
Franz Legros |
Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
|
IL114589A
(en)
|
1990-11-21 |
1999-12-22 |
Roussel Uclaf |
Intermediates for the preparation of the history of erythromycin
|
US5985844A
(en)
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
TW271400B
(sh)
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
FR2697524B1
(fr)
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
JPH07126172A
(ja)
|
1993-11-05 |
1995-05-16 |
Genichiro Soma |
Lpsを含む抗mrsa剤及び動物用抗mrsa剤
|
FR2718450B1
(fr)
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
US5760010A
(en)
|
1995-01-01 |
1998-06-02 |
Klein; Ira |
Method of treating liver disorders with a macrolide antibiotic
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
FR2739620B1
(fr)
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
FR2745290B1
(fr)
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US5719272A
(en)
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
PT1291350E
(pt)
*
|
1996-09-04 |
2005-09-30 |
Abbott Lab |
Cetolidos 6-o-substituidos que possuem actividade antibacteriana
|
AU5597098A
(en)
|
1996-12-13 |
1998-07-03 |
Eli Lilly And Company |
Inhibitors of the enzymatic activity of psa
|
HN1998000074A
(es)
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
US6407074B1
(en)
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
PL337606A1
(en)
|
1997-06-11 |
2000-08-28 |
Pfizer Prod Inc |
Derivatives of erythromycin 9-oxime
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
HU230889B1
(hu)
|
1998-03-26 |
2018-12-28 |
Astellas Pharma Inc. |
Késleltetett felszabadulású gyógyszerkészítmények
|
FR2777282B1
(fr)
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
US6020521A
(en)
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
FR2785612A1
(fr)
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
EP1137654A1
(en)
|
1998-12-10 |
2001-10-04 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
KR20020002380A
(ko)
|
1999-01-27 |
2002-01-09 |
실버스타인 아써 에이. |
케톨라이드 항생물질
|
CA2411293A1
(en)
|
1999-01-28 |
2000-07-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
FR2789392B1
(fr)
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
AR023264A1
(es)
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
JP2000351794A
(ja)
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
CA2370743A1
(en)
|
1999-04-16 |
2000-10-26 |
Dennis Hlasta |
Ketolide antibacterials
|
JP2003523938A
(ja)
|
1999-04-16 |
2003-08-12 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
マクロライド系抗感染剤
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
WO2001010878A1
(fr)
|
1999-08-06 |
2001-02-15 |
Taisho Pharmaceutical Co., Ltd. |
Derives d'erythromycine a
|
WO2001010787A1
(en)
|
1999-08-09 |
2001-02-15 |
Eric Au |
An apparatus for treating wastewater
|
US6096922A
(en)
|
1999-11-01 |
2000-08-01 |
Air Products And Chemicals, Inc. |
Process for the synthesis of dialkyl, diaryl, and arylalkyl aminosulfur trifluorides
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
US20020009507A1
(en)
|
2000-01-19 |
2002-01-24 |
Alcon Universal Ltd. |
Use of polyethoxylated castor oil for the treatment of dry eye
|
JP2001261694A
(ja)
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
CN1193036C
(zh)
|
2000-03-15 |
2005-03-16 |
韩美药品工业株式会社 |
制备甲红霉素-克拉霉素ⅱ型晶体的方法
|
NZ523693A
(en)
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
US20020115621A1
(en)
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
FR2821747B1
(fr)
|
2001-03-09 |
2004-07-02 |
Ethypharm Lab Prod Ethiques |
Suspension de telithromycine a gout masque
|
WO2002094217A1
(en)
|
2001-05-18 |
2002-11-28 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
FR2826274B1
(fr)
|
2001-06-21 |
2003-09-26 |
Aventis Pharma Sa |
Formulation pharmaceutique au gout masque et son procede de preparation
|
JP4509553B2
(ja)
|
2001-07-03 |
2010-07-21 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
抗菌活性を有するc12修飾エリスロマイシンマクロライドおよびケトライド
|
US20030176327A1
(en)
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
WO2003072141A1
(en)
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
ES2566761T3
(es)
|
2002-05-30 |
2016-04-15 |
The Scripps Research Institute |
Ligación de azidas y acetilenos catalizada por cobre
|
JP2005530820A
(ja)
|
2002-06-17 |
2005-10-13 |
エピジェネシス ファーマシューティカルズ リミティド ライアビリティー カンパニー |
二水和デヒドロエピアンドロステロン及びその組成物を用いた喘息又は慢性閉塞性肺疾患の治療方法
|
BR0312634A
(pt)
|
2002-07-08 |
2005-05-10 |
Pliva Istrazivacki Inst D O O |
Novos compostos, composições e métodos para tratamento de doenças e condições inflamatórias
|
US20040013737A1
(en)
|
2002-07-19 |
2004-01-22 |
Philippe Becourt |
Taste masked oral composition of telithromycin
|
AR043050A1
(es)
|
2002-09-26 |
2005-07-13 |
Rib X Pharmaceuticals Inc |
Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
WO2004080391A2
(en)
|
2003-03-10 |
2004-09-23 |
Optimer Pharmaceuticals, Inc. |
Novel antibacterial agents
|
JP2006524702A
(ja)
|
2003-04-25 |
2006-11-02 |
カイロン コーポレイション |
ピリジル置換ケトライド抗体
|
EP1618120A2
(en)
|
2003-04-25 |
2006-01-25 |
Chiron Corporation |
Novel ketolide derivatives
|
DE602004003809T2
(de)
|
2003-05-13 |
2007-10-11 |
Glaxo Group Ltd., Greenford |
Neue 14- und 15-gliedrige ringverbindungen
|
US20050014706A1
(en)
|
2003-07-14 |
2005-01-20 |
Kanakeshwari Falzari |
Method of treating tuberculosis
|
US7457520B2
(en)
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
GB0402578D0
(en)
|
2004-02-05 |
2004-03-10 |
Cambridge Theranostics Ltd |
Methods of treatment of atherosclerosis
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
US20060116336A1
(en)
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
PL1742957T3
(pl)
|
2004-04-28 |
2008-05-30 |
Alembic Ltd |
Sposób otrzymywania telitromycyny
|
US20080255060A1
(en)
|
2004-05-06 |
2008-10-16 |
Sulejman Alihodzic |
Ester Linked Macrolides Useful For The Treatment of Microbial Infections
|
EP1794171A2
(en)
|
2004-07-28 |
2007-06-13 |
Ranbaxy Laboratories, Ltd. |
Ketolide derivatives as antibacterial agents
|
GB0424958D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
GB0424959D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
GEP20094834B
(en)
|
2004-12-21 |
2009-11-25 |
Pfizer Prod Inc |
Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
|
DE602006016231D1
(de)
|
2005-01-14 |
2010-09-30 |
Glaxosmithkline Zagreb |
9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl-y-aminopropyl-azalide mit antimalaria-aktivität
|
US7989600B2
(en)
|
2005-01-14 |
2011-08-02 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
|
JP2008526948A
(ja)
|
2005-01-14 |
2008-07-24 |
グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ |
抗マラリア活性を有する9a−カルバモイルおよびチオカルバモイルアザライド
|
WO2006102308A2
(en)
|
2005-03-22 |
2006-09-28 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin v1b antagonists
|
EP1928440A2
(en)
|
2005-05-25 |
2008-06-11 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
EP1904041A2
(en)
|
2005-07-07 |
2008-04-02 |
Elan Pharma International Limited |
Nanoparticulate clarithromycin formulations
|
US8048874B2
(en)
|
2005-07-19 |
2011-11-01 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
|
WO2007039914A2
(en)
|
2005-10-06 |
2007-04-12 |
Alembic Limited |
Novel polymorphs of telithromycin
|
GB0522715D0
(en)
|
2005-11-08 |
2005-12-14 |
Helperby Therapeutics Ltd |
New use
|
WO2007059307A2
(en)
|
2005-11-15 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Crystalline and amorphous forms of telithromycin
|
EP1957508A2
(en)
|
2005-11-23 |
2008-08-20 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
US20090075916A1
(en)
|
2005-11-23 |
2009-03-19 |
Upadhyay Dilip J |
Use of Macrolide Derivatives for Treating Acne
|
DOP2006000268A
(es)
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
FR2897154B1
(fr)
|
2006-02-08 |
2008-03-07 |
Airbus France Sas |
Dispositif pour construire et securiser une trajectoire de vol a basse altitude destinee a etre suivie par un aeronef.
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
RU2455308C2
(ru)
|
2006-05-01 |
2012-07-10 |
Тайсо Фармасьютикал Ко., Лтд. |
Макролидные производные
|
US20070281894A1
(en)
|
2006-06-05 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
CN101129383B
(zh)
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
US7951905B2
(en)
|
2006-09-18 |
2011-05-31 |
University Of Manitoba |
Synthesis of carbohydrate-templated amino acids and methods of using same
|
US8609148B2
(en)
|
2006-10-25 |
2013-12-17 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
PE20081583A1
(es)
|
2006-12-04 |
2008-12-20 |
Astrazeneca Ab |
Agentes antibacterianos derivados de compuestos carbonilamino
|
JP5025249B2
(ja)
|
2006-12-15 |
2012-09-12 |
Nskワーナー株式会社 |
発進クラッチ
|
AU2008316830B2
(en)
|
2007-10-25 |
2016-03-17 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
EP2220104A1
(en)
|
2007-10-25 |
2010-08-25 |
Sandoz AG |
Process for the production of telithromycin
|
US7795316B1
(en)
|
2007-12-19 |
2010-09-14 |
Alcon Research, Ltd. |
Topical ophthalmic compositions containing tobramycin and dexamethasone
|
US20090209547A1
(en)
|
2008-02-15 |
2009-08-20 |
In Jong Kim |
C-8 halogenated macrolides
|
WO2010048600A1
(en)
*
|
2008-10-24 |
2010-04-29 |
Cempra Pharmaceuticals, Inc. |
Methods for treating resistant diseases using triazole containing macrolides
|
WO2010077730A2
(en)
|
2008-12-09 |
2010-07-08 |
Auspex Pharmaceutical, Inc |
Indanone inhibitors of acetylcholinesterase
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
US8815831B2
(en)
|
2009-06-03 |
2014-08-26 |
Algipharma As |
Treatment of Acinetobacter with alginate oligomers and antibiotics
|
CA2767614C
(en)
|
2009-07-13 |
2019-01-15 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
ES2608285T3
(es)
|
2009-09-10 |
2017-04-07 |
Cempra Pharmaceuticals, Inc. |
Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
|
CN109091489A
(zh)
|
2010-03-10 |
2018-12-28 |
森普拉制药公司 |
大环内酯类抗生素的肠胃外制剂
|
RU2650883C2
(ru)
*
|
2010-03-22 |
2018-04-18 |
Семпра Фармасьютикалз, Инк. |
Кристаллические формы макролида и их применение
|
PL2571506T3
(pl)
|
2010-05-20 |
2017-10-31 |
Cempra Pharmaceuticals Inc |
Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
US9260473B2
(en)
|
2010-07-19 |
2016-02-16 |
Virginia Commonwealth University |
Bivalent multifunctional ligands targeting Aβ oligomers as treatment for Alzheimer's disease
|
US20130164351A1
(en)
|
2010-08-30 |
2013-06-27 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
KR20180110181A
(ko)
|
2010-09-10 |
2018-10-08 |
셈프라 파마슈티컬스, 인크. |
질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
|
WO2012042534A2
(en)
|
2010-09-28 |
2012-04-05 |
Glenmark Generics Limited |
Processes for the preparation of r-sitagliptin and intermediates thereof
|
JP5718488B2
(ja)
|
2011-03-01 |
2015-05-13 |
ウォックハート リミテッド |
ケトライド中間体の調製方法
|
JP6072778B2
(ja)
|
2011-05-23 |
2017-02-01 |
シーイーエム—102 ファーマシューティカルズ,インコーポレイテッド |
フシジン酸を含む組成物およびそのためのパッケージ
|
CA2833241C
(en)
|
2011-08-27 |
2015-05-12 |
Wockhardt Limited |
1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
|
EP2751093A1
(en)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8461188B2
(en)
|
2011-10-20 |
2013-06-11 |
Trius Therapeutics, Inc. |
Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
|
MX2014011537A
(es)
|
2012-03-27 |
2015-02-10 |
Cempra Pharmaceuticals Inc |
Formulaciones parenterales para la administracion de antibioticos macrolidos.
|
EP2968801B1
(en)
|
2013-03-14 |
2018-09-26 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
AU2014233240B2
(en)
|
2013-03-15 |
2018-08-09 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|
MX2020011518A
(es)
|
2013-04-04 |
2022-10-17 |
Harvard College |
Macrólidos y métodos para su preparación y uso.
|
AU2015217293A1
(en)
|
2014-02-14 |
2016-09-01 |
Cempra Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes and liver diseases
|
CN106660945A
(zh)
|
2014-05-27 |
2017-05-10 |
迪法玛弗朗西斯有限公司 |
叠氮基烷基胺盐及其作为中间体的用途
|
BR112017002335A2
(pt)
|
2014-08-05 |
2018-01-16 |
Cempra Pharmaceuticals, Inc. |
formulações de suspensão oral em pó de agentes antibacterianos
|
CN107405355A
(zh)
|
2015-03-06 |
2017-11-28 |
森普拉制药公司 |
用于制备氟酮内酯的方法
|
TW201811811A
(zh)
|
2016-09-02 |
2018-04-01 |
森普拉製藥公司 |
製備氟酮內酯之方法
|